Bifurcations: A Long Return Journey

When it looked like the simplest techniques reach the best outcomes, along came the DK Crush studies. Indeed, after the COVIS III results in bifurcations, it appeared we had started to retrace our steps back to the foundation. 

DKCRUSH-V: El tronco de la coronaria izquierda no es una bifurcación más

The purpose of this study was to compare long term outcomes of the remarkably simple 1-stent strategy to the main vessel (MV) with simple crossover alone vs. an additional side branch (SB) opening procedure with a second guidewire finalized with a kissing balloon.

Patients undergoing coronary PCI to a bifurcation (including left main) with the single stent strategy were included in this registry. 

2,194 patients were divided into the simple crossover–alone group (n=1.685, 76.8%) and the SB-opening group (n=509, 23.2%). Target lesion failure rate (a composite of cardiac death, target vessel myocardial infarction, and target lesion repeat revascularization) was assessed at a 5-year followup. 

The angiographic characteristics of patients in the SB-opening group with kissing balloon were more severe, even though lumen diameter resulted larger in this group. 

After 5 years, target lesion failure rate was similar between groups (7% vs 6.7%; p=0.947). 


Read also: A Headache for Cardiologists: Ischemia with Non-Obstructive Disease.


This was also true for the subgroup with left main lesion (9.5% vs. 11.3%; p=0.442) and lesions classified as Medina 1.1.1, 1.0.1 and 0.1.1 (5.3% vs. 7.8%; p=0.362). The latter are normally called true bifurcations. 

Conclusion

The remarkably simple 1-stent strategy to the main vessel with simple crossover alone showed long term comparable results to those obtained with an additional side branch opening procedure with a second guidewire finalized with a kissing balloon. 

j-jacasi-2021-04-002

Original title: 5-Year Outcome of Simple Crossover Stenting in Coronary Bifurcation Lesions Compared With Side Branch Opening. COBIS III 

Reference: Cheol Hyun Lee et al. JACC: Asia 2021;1:53–64.https://doi.org/10.1016/j.jacasi.2021.04.002


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...